Albany, NY -- (SBWIRE) -- 07/03/2017 -- With a few players holding a massive market share, the global periodontal therapeutics market displays an extremely consolidated competitive landscape, states a new study by Transparency Market Research (TMR). In 2015, the leading participants, namely, 3M, Valeant Pharmaceuticals Int. Inc., and Den-Mat Holdings, acquired a share of 77.7% in the overall market. The leading companies are focusing on research and development of therapies and, for which, they are investing heavily in this market. This, as a result, is expected to intensify the competition within this market in the near future.

Over the coming years, a shift in the focus of key players towards mergers, acquisitions, and partnerships, in order to support their expansion in various regions across the world, can be observed, states the research report.

Read Report with Complete TOC - http://www.transparencymarketresearch.com/periodontal-therapeutics-market.html

As per TMR's estimations, the opportunity in the global periodontal therapeutics market is anticipated to rise at a CAGR of 8.70% over the period from 2016 to 2024 and reach US$537.2 mn by the end of the forecast period. Currently, the demand for systemic antibiotics is much higher than other products in this market. Thanks to the greater affordability, easy availability, and a high market penetration, the demand for these antibiotics will remain rocketing over the next few years, notes the study.

Demand for Periodontal Therapeutics to Remain High in North America

According to the research report, Asia Pacific, North America, Europe, and the Rest of the World, including Latin America, and the Middle East and Africa are the primary geographical segments of the worldwide periodontal therapeutics market. Among these, North America has occupied the leading position and researchers expect the scenario to continue like this in the near future, thanks to the presence of a large patient pool, rise in the healthcare expenditure, and availability of an advanced healthcare infrastructure.

Hospitals pharmacies, drug stores, retail pharmacies, E-commercial sites have emerged as the main distribution channels for the sales of periodontal therapeutics across the world, reports the market study.

Rising Prevalence of Periodontal Disorders to Boost Demand

"The global market for periodontal therapeutics is undergoing a phase of significant growth," says a TMR analyst. The rising prevalence of periodontal disorders, increasing pool of diabetic patients, and the surging research activities for technological advancements in therapeutics are boosting this market significantly. With the approaching expiry of a number of product patients, drug-makers are focusing aggressively on new product launches, which is likely to propel this market in the near future.

The rising awareness level among consumers regarding oral health and the increasing consumption of tobacco are also projected to fuel the demand for periodontal therapeutics over the next few years. However, the upswing in the number of preventive care for dental and gum problems and lack of favorable reimbursement policies in various countries across the world may limit the growth of this market over the forecasts period, notes the research study.

Inquire for a Sample Copy of Report - http://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=24614